Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2001Journal of Antimicrobial Chemotherapy

Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFrancesco BarchiesiMarche Polytechnic University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Francesco Barchiesi (2001) studied this question.

synapsesocial.com/papers/6a6f6e25febe604dd70859abhttps://doi.org/10.1093/jac/48.6.769
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections1997 · 865 citations
  2. 2Oral Azole Drugs as Systemic Antifungal Therapy1994 · 598 citations
  3. 3In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans1999 · 10 citations
  4. 4In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens2000 · 80 citations
  5. 5Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans1995 · 1,188 citations